Evidence based practice
Breakfast Briefing: Regulatory science
Dr Margaret Hamburg, Commissioner Food and Drug Administration, USA
Clinical management of patients with secondary Hyperlipidaemias
Dr Hugh Simpson, Royal Berkshire Hospital, Reading.
Dr Margaret Hamburg, Commissioner Food and Drug Administration, USA
Dr Hugh Simpson, Royal Berkshire Hospital, Reading.